Last year, Kobayashi Kako Co., Ltd., a drug maker in Awara City, Fukui Prefecture, discovered that a drug containing a sleep-inducing agent was mixed with a drug for treating fungal diseases such as water bugs. Announced that it has agreed to hand over the equipment of.
Kobayashi Kako will withdraw from the manufacture and sale of pharmaceutical products.
Kobayashi Kako discovered the problem that a sleep-inducing agent was mixed in the manufactured and sold treatment for athlete's foot and other fungal diseases last year, and stopped manufacturing and selling the drug in order to build a system to prevent recurrence. it is continuing.
Kobayashi Kako Co., Ltd. announced at a meeting on the 3rd that it had agreed to hand over the drug manufacturing plant to Sawai Group Holdings, a major generic drug company headquartered in Osaka.
Of the more than 600 employees working at the factory, about 500 in the production department and quality department will be transferred to the transferee company after confirming their intentions.
After the transfer, Kobayashi Kako will withdraw from the manufacture and sale of pharmaceutical products and will continue to voluntarily collect the products in question remaining on the market and compensate patients with health problems.
At the press conference, Kobayashi Kako's president Hiroaki Tanaka said, "We have made this decision to maximize the employment of employees and to provide early supply of quality pharmaceutical products."
Both companies are aiming to complete the transfer procedure at the end of March next year.